Literature DB >> 25620734

[Painful ischemic neuropathy].

P M Lang1.   

Abstract

Chronic ischemia in patients with peripheral arterial disease (PAD) represents a common medical problem. Neuropathic changes and pain caused by chronic ischemia are often found in the lower extremities of these patients. Pain in patients with chronic critical limb ischemia fulfill the criteria of neuropathic pain. Diagnostic tools besides medical history and examination are questionnaires, quantitative sensory testing (QST) and measuring intraepidermal nerve fiber density (IENFD) when indicated. A pharmacological approach with non-opioids and opioids as well as antidepressive and anticonvulsive drugs (according to the recommendations for the therapy of neuropathic pain) seems to be indicated for treating painful ischemic neuropathy. Spinal cord stimulation (SCS) provides the best evidence for invasive procedures in treating chronic ischemic pain.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25620734     DOI: 10.1007/s00115-014-4125-4

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  11 in total

Review 1.  [Pain in chronic peripheral arterial occlusive disease. Pathogenesis and therapy].

Authors:  H Rieger; A Scheffler
Journal:  Internist (Berl)       Date:  1999-02       Impact factor: 0.743

Review 2.  Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.

Authors:  Robert H Dworkin; Miroslav Backonja; Michael C Rowbotham; Robert R Allen; Charles R Argoff; Gary J Bennett; M Catherine Bushnell; John T Farrar; Bradley S Galer; Jennifer A Haythornthwaite; David J Hewitt; John D Loeser; Mitchell B Max; Mario Saltarelli; Kenneth E Schmader; Christoph Stein; David Thompson; Dennis C Turk; Mark S Wallace; Linda R Watkins; Sharon M Weinstein
Journal:  Arch Neurol       Date:  2003-11

3.  Peripheral neuropathy in chronic venous insufficiency.

Authors:  F Reinhardt; T Wetzel; S Vetten; M Radespiel-Tröger; M J Hilz; D Heuss; B Neundörfer
Journal:  Muscle Nerve       Date:  2000-06       Impact factor: 3.217

4.  Sensory neuropathy and signs of central sensitization in patients with peripheral arterial disease.

Authors:  Philip M Lang; Gabriel M Schober; Roman Rolke; Susanne Wagner; Robert Hilge; Martin Offenbächer; Rolf-Detlef Treede; Ulrich Hoffmann; Dominik Irnich
Journal:  Pain       Date:  2006-05-22       Impact factor: 6.961

5.  Reduced intraepidermal nerve fiber density in patients with chronic ischemic pain in peripheral arterial disease.

Authors:  Eva Gröne; Nurcan Üçeyler; Thomas Abahji; Johannes Fleckenstein; Dominik Irnich; Thomas Mussack; Ulrich Hoffmann; Claudia Sommer; Philip M Lang
Journal:  Pain       Date:  2014-06-12       Impact factor: 6.961

6.  Characteristics of chronic ischemic pain in patients with peripheral arterial disease.

Authors:  Linda J Rüger; Dominik Irnich; Thomas N Abahji; Alexander Crispin; Ulrich Hoffmann; Philip M Lang
Journal:  Pain       Date:  2008-05-09       Impact factor: 6.961

7.  Gabapentin (Neurontin) improves pain scores of patients with critical limb ischaemia: an observational study.

Authors:  Gareth Morris-Stiff; Michael H Lewis
Journal:  Int J Surg       Date:  2010-01-11       Impact factor: 6.071

8.  High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study.

Authors:  Curt Diehm; Alexander Schuster; Jens R Allenberg; Harald Darius; Roman Haberl; Stefan Lange; David Pittrow; Berndt von Stritzky; Gerhart Tepohl; Hans-Joachim Trampisch
Journal:  Atherosclerosis       Date:  2004-01       Impact factor: 5.162

9.  Axonal neuropathy in chronic peripheral arterial occlusive disease.

Authors:  Frank Weber; Andrea Ziegler
Journal:  Muscle Nerve       Date:  2002-10       Impact factor: 3.217

Review 10.  Review of the cardiovascular safety of COXIBs compared to NSAIDS.

Authors:  I Moodley
Journal:  Cardiovasc J Afr       Date:  2008 Mar-Apr       Impact factor: 1.167

View more
  1 in total

1.  In Reply.

Authors:  Benedikt Schoser; Claudia Sommer; Christian Geber; Raimund Forst; Peter Young; Frank Birklein
Journal:  Dtsch Arztebl Int       Date:  2018-04-27       Impact factor: 5.594

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.